RE:RE:RE:RE:RE:Long term contract with Labs They wont need them soon enough Southy, seems to me that Supreme is cutting the middle man out of the equation as much as possible. In-house genetics, packaging, extracts, premium flower, and soon in house pre rolls and vapes(this is the real definitions of a PRODUCER). Noticed all the contracts we've signed with all these companies are small enough that we're not tied at the hips with them. We can't become Apha, and buy for a premium while making small margins on sales....
Really looking forward to hearing Blissco achieved it's GMP certificate, the EU market will open up in the next few years, and it's set to be 150bn+ market. Also looking forward to hearing the whole of 7Acres is under crop. Going to be interesting to see just how cheap we can grow flower per gram when the economics of scale come to fruition.
Southybird wrote: I agree they are a good partner in terms of product...I actually thought they were a good aquisition target in and around Nov/Dec 2018 when the agreement was made and LABs was under a buck...
That being said I did reach out to IR on this and they have comfirmed the relationship is in good standing.
The agreement between the two is what was disclosed and referenced in 2018. Nothing more.
That being said, just like the Namaste bullshite, its time to cut LABs lose as they are giving these scumbag shorters more ammo to comfuse the markets with. Its poor logic imo to make a statment of claim inference when you have multiple partners who are in good standing.
imo Good Luck all.